Paradigm Biopharmaceuticals Ltd.ASX: PAR

Trading Halt

Sep 20, 2026 at 6:47 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · Sep 20, 2026 at 6:47 PM EDT

On 6ix: 6ix.com/news/trading-halt-2026

Market Announcement 21 September 2026 21 September 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au #11142542v1 Paradigm Biopharmaceuticals Limited (ASX: PAR) – Trading Halt Trading in the securities of Paradigm Biopharmaceuticals Limited...

View Attachment

6ix hasn’t read this filing yet.

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Application for quotation of securities - PARSep 17
Dr Daniel Furtner appointed Chief Medical OfficerSep 14
Notice under Section 708ASep 10
Notification regarding unquoted securities - PARSep 10
Drawdown of Tranche 4 under the Convertible Note FacilitySep 10

Later from Paradigm Biopharmaceuticals

Suspension from QuotationSep 22
Phase 3 Interim Result Below Continuation ThresholdSep 23
Notification of cessation of securities - PARSep 24
Agreement to Return US$2M to ObsidianSep 24
Continuation of Voluntary SuspensionSep 27

All Paradigm Biopharmaceuticals news releases

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals